Resources

Commissioner

NHS England, CCGs and local authorities are all responsible for commissioning different parts of hepatitis C testing, treatment and care.  Find here tools, templates and other relevant documents to assist commissioners with their responsibilities to ensure hepatitis C patients are diagnosed and receive high quality care.

Showing 1 to 10 of 324 resources

  • Webinar: Mitigating the impact of COVID-19 on hepatitis C testing
    This is a recording of a webinar focusing on how services can mitigate the impact of COVID-19 on hepatitis C testing and find alternative ways to test people. The first part of the webinar consisted of three presentations: 1/ Overview of testing, before and after COVID-19 - Helen Hampton, Lead Clinical Nurse for Blood Borne Virus, We Are With You 2/ Outreach testing during the COVID-19 lockdown - Julian Surey, Find and Treat Team 3/ Postal testing or self-testing - Tracey Kemp, National Hepatitis C Strategy Lead, Change Grow Live
    UK 22 Oct 2020 Case study, Tools & Templates, Strategy & Planning Video
  • Summary report: Hepatitis C case-finding in under-served groups - October 2020
    This report summarises the October 2020 HCV Action webinar on hepatitis C case-finding in under-served groups, which formed part of a week-long series of webinars centred around the National Hepatitis C ODN Stakeholder Event. The webinar focused on four under-served groups in particular: Gypsy, Roma and Travellers; migrants; sex-workers, and the South Asian community. The webinar featured contributions from the following speakers: • Beth Davies – Head of Service and Development (Dorset), EDP Drug & Alcohol Services • Dr Inês Campos-Matos – Head of Migration Health, Public Health England
    UK 22 Oct 2020 Reports & Research PDF
  • HCV Action ODN Stakeholder Event 2020: A national perspective on elimination
    These are the opening talks from this year's ODN Stakeholder Event from Mark Gillyon-Powell, Head of Programme for HCV Elimination, NHS England and Prof Graham Foster, National Clinical Lead for ODNs, NHS England. The talks gives a national overview on hepatitis C elimination efforts in England and how COVID-19 has impacted these. Professor Guruprasad Aithal, President of the British Association for the Study of the Liver (BASL) chaired the event. We will be publishing a written summary of the other presentations from this event soon.
    England 07 Oct 2020 Other, Strategy & Planning Video
  • Unlinked Anonymous Monitoring (UAM) Survey of HIV and viral hepatitis among PWID: 2020 report
    The 2020 edition of the Unlinked Anonymous Monitoring (UAM) Survey of HIV and viral hepatitis among PWID contains a number of relevant updates on hepatitis C among injecting drug users, including: • The proportion of UAM participants with antibodies to hepatitis C (HCV) (i.e. ever infected) who have markers of chronic infection (RNA) has decreased from 58% in 2011 when it was first measured to 42% in 2019; this corresponds with the timing of the scale-up of direct acting antiviral treatment against HCV among PWID
    UK 06 Oct 2020 Reports & Research PDF
  • Understanding the Sexual Health and Blood Borne Virus Risk Behaviours of Defined 'at risk' Groups
    This report outlines the findings of research with drug users and the staff that support them related to harms associated with chemsex, transactional sex; and the use of image and performance enhancing drugs (IPEDs). Twos aims of the report were to describe the risk-taking behaviours in relation to drug taking, sexual health and transmission of BBV (blood borne virus) of the three target groups and inform the development of a training programme for services providers on sexual health and blood borne viruses for the three defined groups.
    Scotland 07 Sep 2020 Reports & Research PDF
  • Lessons learnt from HepCATT for ODNs and GP practices
    This summary notes some of the lessons learnt from the HepCATT (Hepatitis C Assessment Through to Treatment) Randomised Controlled Trial. HepCATT tested an Hepatitis C virus (HCV) case-finding intervention in primary care. The intervention involved: • Algorithm integrated into electronic patient records systems to identify high risk patients • Automatic mail-merge to create letters to invite high risk patients for testing • Pop-ups alerts in patient records to encourage opportunistic testing • Practice Staff HCV educational training
    UK, England Training, Tools & Templates, Strategy & Planning PDF
  • Good practice case study: Pop-up hepatitis C testing for people in supported accommodation during the COVID-19 outbreak
    During the COVID-19 pandemic, the ‘Everyone In’ policy meant that people who would otherwise be homeless were given accommodation in hotels. Surrey Operational Delivery Network, like many other ODNs, used this as an opportunity to engage with this cohort, offering testing and treatment for hepatitis C. This case study details how the team from Royal Surrey County Hospital and The Hepatitis C Trust were able to test people in these hotels and other forms of accommodation.
    UK, England, South East Case study, Strategy & Planning PDF
  • Good practice case study: Hepatitis C care for homeless individuals in Slough
    This good practice case study, produced by the Turning Point substance misuse service, highlights recent work carried out by nurse and hepatitis C champion Fay Smith in collaboration with colleagues. With previously-homeless individuals accommodated following the Covid-19 outbreak, the opportunity was seized to offer hepatitis C testing and treatment to this cohort.
    South East 17 Aug 2020 Case study PDF
  • Summary Report: Hepatitis C services in Scotland during and beyond the Covid-19 outbreak - August 2020
    With the Covid-19 outbreak having caused significant disruption to health services in Scotland, including those for hepatitis C, as well as drug and alcohol services, HCV Action organised a webinar to discuss how services and the drive to elimination in Scotland have been affected. This report provides a summary of the remarks from each of the four speakers and the Q&A which followed.
    Scotland Case study, Reports & Research, Tools & Templates, Strategy & Planning PDF
  • HCV Action webinar: Hepatitis C services in Scotland during and beyond Covid-19
    With the Covid-19 outbreak having caused significant disruption to healthcare services, including those for hepatitis C, this webinar was organised to discuss how services have been affected in Scotland and explore how hepatitis C services can most effectively be re-established as we emerge from the early phase of the outbreak. The webinar featured contributions from the following speakers: Professor John Dillon - Clinical Lead for Blood Borne Viruses, NHS Tayside Leon Wylie - Lead Officer, Hepatitis Scotland Rachel Halford - CEO, The Hepatitis C Trust
    Scotland 05 Aug 2020 Training, Tools & Templates, Strategy & Planning Video

Pages